Hydrogen sulfide (H 2 S) is an endogenous gaseous transmitter, similar to other gaseous signal molecules, such as carbon monoxide (CO) and nitric oxide (NO). H 2 S influences numerous physiological and pathological processes, 1,2 including protection against ischemia, 3,4 pressure overload, 5 doxorubicin toxicity, 6 inflammation, 7 and blood vessel relaxation. 8, 9 In mammalian tissues, H 2 S is produced through degradation of l-cysteine mainly by 2 main enzymes: cystathionine-β-synthase and cystathionine-γ-lyase. 10 Myocardial tissues contain low amounts of cystathionine-β-synthase but abundant cystathionine-γ-lyase. 11, 12 Renovascular hypertension caused by partial renalartery stenosis results in persistent high blood pressure and increased angiotensin II (Ang II) activity. 13,14 Ang II, which functions via the Ang II type 1 receptor (AT1R), increases the activity of nicotinamide adenine dinucleotide phosphate oxidase. This phenomenon is proposed as the mechanism underlying the enhanced production of reactive oxygen species (ROS), especially superoxide anion in a rat model of renovascular hypertension. 15 Increased production of superoxide anion has been associated with endothelial dysfunction in experimental and human renovascular hypertension. [16] [17] [18] ROS is associated with the development and progression of various cardiovascular diseases. 16 H 2 S exhibits physiological functions against ischemiareperfusion-induced heart injury 3,19 and endotheliumdependent relaxation in the thoracic aorta. 20 Shi et al. 21 reported a possible function of H 2 S against medial thickening of intramyocardial coronary arterioles, as well as interstitial ROS production in spontaneously hypertensive rats. Moreover, the plasma level of H 2 S was significantly reduced in spontaneously hypertensive rats 22 and renovascular hypertensive rats. 20, 23 We have shown that H 2 S improves the endothelial function and decreases blood pressure in 2-kidney 1-clip (2K1C) rats. 20 These results suggest that the protective effect of H 2 S can be attributable to the suppression 
of oxidative stress which involves the inhibition of Ang II/AT1R pathway.
In this study, the plasma H 2 S concentration was reduced and the AT1R protein was upregulated in the myocardial tissue of 2K1C rats compared with that in normotensive rats. Therefore, we hypothesize that the loss of H 2 S in 2K1C rats would result in an attenuated inhibition of Ang II/AT1R pathway (or an enhanced Ang II/AT1R pathway), thereby leading to myocardial remodeling. We tested this hypothesis by administrating Sodium hydrosulfide (NaHS) intraperitoneally (i.p.) to rats from the 7th day post-2K1C operation.
METHODS

Animals and treatment protocols
A 2K1C rat model was built to induce renal vascular hypertension. Sprague-Dawley male rats, weighting 160-180 g were randomly allocated to 2K1C and sham-operated (sham) groups. Animals in the 2K1C group were anesthetized with sodium pentobarbital (60 mg/kg, i.p.). The left kidney of the rat was exposed through a lumbar incision. Then the left renal artery was isolated free and clipped by a rigid V-shaped silver clip with 0.22 mm slit. Sham-operated rats underwent the same surgical procedure except for clip placement. The systolic blood pressure (SBP) was measured after 1 week using tail-cuff system (NIBP, AD Instruments, Sydney, Australia). The 2K1C rats with both SBP above 150 mm Hg and at least 40 mm Hg higher than preoperation condition were chosen from the groups. The 2K1C hypertensive rats were randomly allocated to 2K1C and 2K1C + NaHS groups. Sham-operated animals were randomly allocated to sham and sham + NaHS groups. The 2K1C + NaHS and sham + NaHS groups were treated NaHS (56 µmol/kg/day, i.p.,) for 4 weeks. 2K1C and sham groups received saline treatment. All procedures were performed in accordance with the Guidelines for Animal Experiments in Hebei Medical University.
Measurement of cardiac function and tissue preparation
Animals were fasted overnight with free access to water after drug treatment for 4 weeks. The rats were anesthetized with urethane (1.5 g/kg, i.p.). Then, a PE-50 catheter filled with heparin saline (500 U/ml) was carefully inserted into the left ventricle from the right carotid artery to record the left ventricular end diastolic pressure, left ventricular systolic pressure, and maximal/minimal left ventricular pressure development (±dp/dt max ).
Blood was collected from the inferior vena cava after the cardiac function was evaluation. Then the heart was excised and rinsed in cold potassium phosphate buffer (PBS, pH 7.4). The left ventricle with septum was separated and then weighted together. The ratio of the left ventricle and septum weight to body weight (LVW/BW) was calculated. Tissue (80-100 mg) near the apex of heart was separated frozen separately in liquid nitrogen, and then stored at −80 °C until use.
Morphology and histological analyses
The residual left ventricle was perfused with PBS followed by 4% polyformaldehyde. Then, the specimen was embedded with paraffin, continuously cross-sectioned with 4 µm thickness, and stained with hematoxylin and eosin. Cardiomyocytes were observed in each section at high-power magnification. The cross-sectional area of cardiomyocytes was measured under a video camera (Olympus, Japan) attached to a micrometer in 20 different randomly chosen high-power fields in each cross-section of the left ventricle.
Measurement of Ang II and H 2 S concentration
We used radioimmunoassay to measure Ang II concentration. The blood sample was collected in a tube and mixed with EDTA and enzyme inhibitors in ice. The sample was centrifuged at 3,000 rpm for 15 minutes at 4 °C. The plasma was collected and examined with an Ang II radioimmunoassay kit (China Institute of Atomic Energy, Beijing, China). All samples were assayed in duplicate according to the manufacturer's instructions.
H 2 S concentration in the plasma was measured as described in previous publications. 24, 25 Aliquots (100 µl) of the plasma were mixed with PBS (pH 7.4, 350 µl) and zinc acetate (1% w/v, 25 µl) followed by incubation with N, N-dimethylp-phenylenediamine sulfate (20 mmol/l, 133 µl) mixed in 7.2 mol/l HCl and FeCl 3 (30 mmol/l, 133 µl) mixed in 1.2 M HCl. Reactions were terminated by trichloroacetic acid (10% w/v, 250 µl) after 30-minute color development. The resulting solutions (300 µl) were transferred to a 96-well plate and the absorbance of the mixtures (665 nm) was measured. H 2 S was calculated against a calibration curve of NaHS (0.01-100 µmol/l).
Cell culture and treatment
Primary neonatal rat cardiomyocytes were collected as previously described. 26 Briefly, minced hearts were digested with 0.05% collagenase I and 0.025% trypsin in a 37 °C water bath. Isolated cardiomyocytes were cultured in dulbecco's modified eagle medium (DMEM) containing 10% fetal bovine serum (FBS), penicillin (100 U/ml), and streptomycin (100 U/ml) in an incubator (37 °C under 5% CO 2 ). The medium contained 100 mM 5-bromo-20-deoxyuridine (BrdU) to prevent the proliferation of fibroblasts. The cells were treated with drugs after 72 hours.
Detection of ROS levels
ROS level in cardiomyocytes was measured by 2′, 7′-dichlorodihydrofluorescein diacetate (DCFH-DA) fluorescence using confocal microscopy. After a 24-hour period of drug treatment, cells were washed 3 times with D-Hank's buffer. Then, DCFH-DA (1 µg/ml, dissolved in DMEM without FBS, SigmaAldrich, St. Louis, MO) was added for 30 minutes at 37 °C in the dark. Images were captured using a confocal laser scanning microscope (Leica, Wetzlar, Germany) with 488 nm excitation/525 nm emission setting. Mean fluorescence intensity was calculated by averaging the intensities of areas outlined from cardiomyocytes isolated at least 3 different samples.
Western bolt for tissue and cardiomyocytes
Tissue and cells were homogenized in ice-cold radioimmunoprecipitation assay buffer containing protease inhibitor and phosphatase inhibitor cocktail (SigmaAldrich). Homogenized samples were sonicated and centrifuged at 12,000 rpm for 20 minutes at 4 °C. Protein concentrations were measured with the BCA protein assay kit (Generay Biotechnology, Shanghai, China). The protein samples (40 µg) were electrophoresed through 10% sodium dodecyl sulfate-polyacrylamide gel and then transferred onto an Immobilon-P polyvinylidene difluoride membrane using wet transfer at 100 V for 90 minutes at 4 °C. The membrane was blocked with 0.05% Tween-20 Tris-buffered saline containing 5% nonfat milk for 60 minutes at room temperature. The blots were then incubated overnight at 4 °C with anti-AT1R (Abcam, Hong Kong) and antisuperoxide dismutase (SOD)-1 (Santa Cruz Biotechnology). The samples were washed 3 times with Tris-buffered saline. Then, the nitrocellulose was incubated with horseradish peroxidase-conjugated goat anti-rabbit IgG (Proteintech, Chicago, IL). GAPDH (Bioworld Technology) was used as a loading control. Blots were developed with an enhanced chemiluminescence detection system (Sagecreation, Beijing, China). Densitometry was performed using lane-1 system (Sagecreation).
Statistical analysis
Results were expressed as means ± SEM. Statistical analysis was performed using SPSS version 13.0 (SPSS, Chicago, IL). The results for 3 or more groups were compared using 1-way analysis of variance followed by Student-NewmanKeuls test. P <0.05was considered statistically significant.
RESULTS
H 2 S reduced SBP in 2K1C rats
H 2 S was treated daily for 4 weeks after 1 week of hypertension, and SBP gradually decreased in 2K1C + NaHS rats. However, no obvious changes were observed in the shamoperated animals. Before drug treatment, SBP was significantly higher in the 2K1C rats (158.73 ± 13.81 mm Hg,) than in the sham rats (112.85 ± 4.74 mm Hg, P < 0.01). SBP of 2K1C rats become stabilized after 2 weeks' increment postopreration. NaHS gradually reduced SBP in the 2K1C rats within a week from the beginning of drug treatment (Figure 1a) .
Change in plasma H 2 S and Ang II concentration
Plasma H 2 S concentration of the different groups were measured after NaHS treatment for 4 weeks. The results show significantly reduced H 2 S in 2K1C rats (40.7 ± 3.5 µmol/l) than Figure 1 . Effects of NaHS on SBP, plasma H 2 S and plasma Ang II in 2K1C hypertensive rats. (a) Development of SBP in the 4 experimental groups during a 5-week period. The SBP increased significantly compared with the sham group after 1 week of surgery. NaHS for 4 weeks could reverse the change in the 2K1C group. Data are expressed as mean ± SD, n = 6 for each group.*P < 0.01 vs. sham group; # P < 0.01 vs. 2K1C group. (b) Plasma H 2 S concentration in different groups. (c) Plasma Ang II concentration in different groups. The plasma H 2 S decreased significantly and Ang II increased in the 2K1C group compared with in the sham group. NaHS for 4 weeks could reverse these changes in the 2K1C group. Data are expressed as mean ± SD. A P of <0.05 was considered significant. Abbreviations: Ang II, angiotensin II; H 2 S, hydrogen sulfide; N.S., nonsignificant; NaHS, sodium hydrosulfide; SBP, systolic blood pressure; 2K1C, 2-kidney 1-clip.
in sham rats (48.4 ± 2.3 µmol/l, P < 0.001), and plasma H 2 S concentration was significantly higher in 2K1C + NaHS rats than in 2K1C rats. No difference was found in the plasma H 2 S concentration between sham + NaHS and sham rats (Figure 1b) . Figure 1c indicates the plasma Ang II concentration increased in 2K1C rats (881.0 ± 53.2 pg/ml) compared with the sham rats (339.8 ± 32.2 pg/ml, P < 0.001). Moreover, the present data show a significant decrease in Ang II level in 2K1C + The +dp/dt, −dp/dt, and LVSP decreased significantly in the 2K1C group compared with in the sham group. NaHS for 4 weeks could reverse these changes in the 2K1C group. LVEDP showed no difference in all groups. Data are expressed as mean ± SD. A P of <0.05 was considered significant. Abbreviations: LVEDP, left ventricular end diastolic pressure; LVSP, left ventricular systolic pressure; N.S., nonsignificant; NaHS, sodium hydrosulfide; 2K1C, 2-kidney 1-clip; ±dp/dt max , maximal/minimal left ventricular pressure development. NaHS rats (554.8 ± 80.3 pg/ml, P < 0.001) than in 2K1C rats. No differences in plasma Ang II were found in the sham groups.
H 2 S protect cardiac function
Figure 2a-d showed no difference in left ventricular end diastolic pressure among the different groups after NaHS treatment for 4 weeks. Left ventricular systolic pressure was significantly lower in the 2K1C rats (105.68 ± 15.06 mm Hg) than in sham rats (161.66 ± 18.62 mm Hg, P < 0.001). Left ventricular systolic pressure was significantly higher in 2K1C + NaHS rats (133.12 ± 6.79 mm Hg, P = 0.004) than 2K1C rats. The +dp/dt max was significantly lower in 2K1C rats (4862.70 ± 1010.64 mm Hg/s) than sham rats (9548.71 ± 1966.88 mm Hg/s, P < 0.001), as expected. The +dp/dt max was significantly higher in 2K1C + NaHS rats (7160.41 ± 1105.48 mm Hg/s, P = 0.005) than in 2K1C rats. The absolute value of −dp/dt max was significantly lower in the 2K1C rats (4371.63 ± 857.94 mm Hg/s) than sham rats (7457.16 ± 480.25 mm Hg/s, P < 0.001). The absolute value of −dp/dt max was higher in 2K1C + NaHS rats (6727.95 ± 863.55 mm Hg/s, P < 0.001) than in 2K1C rats. Sham + NaHS rats (7338.63 ± 698.32 mm Hg/s) showed no difference with sham rats.
H 2 S protects against cardiac hypertrophy
The ratio of LVW/BW was higher in 2K1C rats (2.60 ± 0.21) than in sham rats (2.02 ± 0.13, P < 0.001). LVW/BW was significantly lower in 2K1C + NaHS rats (2.21 ± 0.28, P < 0.001) than in 2K1C rats. Sections of cardiac muscle were stained with hematoxylin and eosin, and cross-sectional area of cardiomyocytes was observed under light microscope. The cross-sectional area was higher in the 2K1C rats than in the sham rats (P < 0.001), and cross-sectional area of cardiomyocytes was significantly lower in 2K1C + NaHS rats than in 2K1C rats. Light microscope observations showed fibrotic changes in the extracellular matrix of cardiomyocytes and perivascular area in the coronary artery (Figure 3 ).
In vitro treatment with H 2 S protects against Ang II-induced cardiomyocytes injury
ROS production significantly increased in the Ang II (10 −6 M) group than in the control group (without Ang II). NaHS (200 µM) reduced Ang II-induced ROS production. Losartan (10 −6 M), a AT1R blocker, as well as N-acetylcysteine (NAC, 10 −5 M)) could also reduce Ang II-induced ROS production. When compared with the control group, Ang II + NaHS, Ang II + losartan, and Ang II + NAC groups show no remarkable difference in ROS production compared with the control group (Figure 4) .
Effect of H 2 S on AT1R and SOD-1 in vivo and in vitro
Western blot analysis was used to determine AT1R and SOD-1 protein expression in the left ventricle in the 4 groups of animals. The results show that protein level of AT1R was elevated in 2K1C rats. The overexpression of AT1R was reversed by chronic treatment with NaHS. The SOD-1 protein in left ventricle of 2K1C rats was significantly increased. Treatment with NaHS for 4 weeks normalized the tissue level of protein SOD-1 ( Figure 5 ).
AT1R protein was upregulated and SOD-1 protein was downregulated in vitro in the Ang II (10 −6 M) group compared with in the control group (without Ang II). The overexpression of AT1R protein induced by Ang II (10 −6 M) was significantly reversed by NaHS (200 µM), losartan (10 −6 M), as well as NAC (10 −5 M). Ang II (10 −6 M) could decrease SOD-1 protein, but this change was normalized by NaHS (200 µM), losartan (10 −6 M), as well as NAC (10 −5 M) (Figure 6 ).
DISCUSSION
The major findings of this study are as follows: (i) NaHS reduces SBP in 2K1C hypertensive rats and (ii) NaHS could partly improve myocardial remodeling and ventricular dysfunction in 2K1C hypertensive rats. This study is the first to report that H 2 S downregulates AT1R, upregulates SOD-1 protein expression in myocardial tissue and reduces plasma Figure 4 . ROS production in different groups. The ROS level increased significantly in the Ang II group compared with in the control group (without Ang II). NaHS could reverse the change in the Ang II group. Losartan and ROS scavenger NAC, similar to NaHS, could also reverse the Ang II-induced change. Data are expressed as mean ± SD. A P of <0.05 was considered significant. Abbreviations: Ang II, angiotensin II; con, control group; N.S., nonsignificant; NAC, N-acetylcysteine; NaHS, sodium hydrosulfide; ROS, reactive oxygen species. The AT1R increased and SOD-1 decreased significantly in the Ang II group compared with in the control group (without Ang II) in vitro. NaHS could reverse these changes in the Ang II group. Losartan and ROS scavenger NAC, similar to NaHS, could also reverse the Ang II-induced changes. Data are expressed as mean ± SD. A P of <0.05 was considered significant. Abbreviations: Ang II, angiotensin II; AT1R, angiotensin II type 1 receptor; con, control group; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; N.S., nonsignificant; NAC, N-acetylcysteine; NaHS, sodium hydrosulfide; SOD-1, superoxide dismutase 1. Ang II of 2K1C hypertension rats. These results suggest that the beneficial effects of H 2 S might be mediated through the downregulation of the Ang II/AT1R pathway in 2K1C rats.
H 2 S is the third gasotransmitter following NO and CO. 1,2 Abe and Kimura 27 found that H 2 S can be endogenously generated and regulates human physiological functions. 2K1C, which was used in this study, is a hypertension model with high renin levels. Renal stenosis overactivates the renin-angiotensin system, which is involved in myocardial remodeling 28 and vascular remodeling. 29 Growing evidence suggests that Ang II induces ROS generation mainly by mediating AT1R activation. 30 Furthermore, Ang II exerts growth factor effects on cardiomyocytes and fibroblasts. 31 Ang II has been reported to be upregulated in renovascular hypertension. NaHS (56 µmol/kg/ day) decreased blood pressure, improved endothelial function, and reduced vascular superoxide production in 2K1C rats. 20 However, the effect of NaHS on myocardial remodeling and ventricular dysfunction in renovascular hypertension remain poorly studied. In accordance with these previous studies, 28 our present study also reveals that 2K1C treatment result in prominent myocardial remodeling and ventricular dysfunction. In addition, we found that NaHS treatment lowered blood pressure in 2K1C hypertensive rats, which is consistent with previous reports. 20, 23 Furthermore, we also found that the myocardial remodeling and ventricular dysfunction was significantly improved by the NaHS in 2K1C hypertensive rats. These results suggest that treatment with NaHS improves myocardial remodeling and ventricular function in a 2K1C-induced hypertensive rat model. These observations support the speculation that downregulation of H 2 S may be responsible for the myocardial remodeling and ventricular dysfunction in 2K1C rats.
Association between myocardial remodeling and oxidative stress has been extensively reported in hypertension, including essential, renovascular, or malignant hypertension. 32, 33 Myocardial remodeling improvement may be the mechanism underlying the effects of NaHS. Renin-angiotensin system in heart physiology is important in regulating blood volume, systemic vascular resistance, and cardiac function. 34 Moreover, Lu et al. 23 found that H 2 S could decrease plasma renin activity in 2K1C rats. The results from the present study show that NaHS treatment lowered plasma level of Ang II and downregulated the AT1R protein expression in myocardial tissues of 2K1C hypertensive rats. These results suggest H 2 S improves myocardial remodeling and ventricular dysfunction by downregulating Ang II/AT1R pathway.
SODs are the major antioxidant systems against superoxide anions. 35 SOD-1 is an antioxidant isoenzyme which catalyzes the conversion of superoxide anions into hydrogen peroxides. This enzyme can modulate myocardial remodeling and ventricular function. A recent study has shown that SOD-1 improves postinfarct myocardial remodeling. 36 These findings indicate the importance of superoxide anions in the control of myocardial remodeling and ventricular function. In the present study, the SOD-1 significantly decreased in the 2K1C group compared with in the sham group. NaHS for 4 weeks could reverse the change in the 2K1C group. Therefore, our results demonstrate the potent antioxidant effect of H 2 S on myocardial tissues of renovascular hypertensive rats. The present study provides evidence for the H 2 S protective role on myocardial tissues by suppressing myocardial tissue oxidative stress through inhibition of Ang II/AT1R action and upregulated antioxidant enzyme SOD-1 within the myocardial tissue of 2K1C hypertension rats.
Ang II is an upstream regulator of cardiac oxidases and intracellular ROS in cardiomyocytes. 30 Moreover, Ang II activates nicotinamide adenine dinucleotide phosphate to produce ROS via AT1R by modulating a series of intracellular pathways. 37, 38 Our results are consistent with the speculation that NaHS treatment reduces SBP, lowers plasma level of Ang II, downregulates AT1R protein expression, and improves myocardial remodeling and ventricular dysfunction in 2K1C hypertensive rats. Thus, whether these effects were due to the direct actions of H 2 S on myocytes or to its inhibiting action on blood pressure should be elucidated. We found that incubation of Ang II-treated cardiomyocytes with NaHS in an isolated cell culture system resulted in the downregulation of the protein expression of the AT1R and reduced ROS production, whereas SOD-1 protein was upregulated. These results suggest that the protective effect of H 2 S, at least in part, was implemented directly through the downregulation of Ang II/AT1R/ROS pathway on myocytes. Furthermore, we also found that losartan, the AT1R blocker, abolished the effects of Ang II-induced ROS production. This finding implies that the downregulation of ROS production effects of H 2 S in the cardiomyocyte by Ang II treatment is mediated by AT1R protein.
It is well known that ROS have been reported to induce oxidative damage and play a role in myocardial fibrogenesis. 39 Nishida et al. 40 found that endogenous ROS upregulated AT1R expression in rat cardiac fibroblasts. Consistent with those findings, in the current study, we found that treatment of ROS scavenger NAC also downregulated the Ang II-induced AT1R expression. These data indicate that the H 2 S production reduces ROS production, which in turn plays a functional role in inhibiting AT1R protein in Ang II-treated myocardial cells.
In conclusion, 2K1C-induced hypertension in rats leads to myocardial remodeling and ventricular dysfunction. However, these effects are alleviated by NaHS treatment. The protective effects of H 2 S are partly attributed to the suppression of myocardial oxidative stress by inhibiting the Ang II/AT1R pathway, and upregulating the antioxidant enzyme SOD-1. H 2 S is a promising agent for long-term battle against hypertensive heart diseases and may become a valuable target for cardioprotective therapies.
